Study of RH-1 in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Clinical trial NCT00558727 · TERMINATED
Trial details
- NCT number
- NCT00558727
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2008-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.